Compare KINS & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | KINS | PMI |
|---|---|---|
| Founded | 1886 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.7M | 202.7M |
| IPO Year | 2013 | N/A |
| Metric | KINS | PMI |
|---|---|---|
| Price | $15.70 | $0.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 124.7K | ★ 1.7M |
| Earning Date | 05-07-2026 | 06-18-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 94.59 | N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | ★ $214,867,301.00 | N/A |
| Revenue This Year | $24.23 | N/A |
| Revenue Next Year | $18.05 | N/A |
| P/E Ratio | $5.60 | ★ N/A |
| Revenue Growth | ★ 38.50 | N/A |
| 52 Week Low | $13.08 | $0.40 |
| 52 Week High | $22.20 | $13.68 |
| Indicator | KINS | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 41.08 | 18.53 |
| Support Level | $14.13 | N/A |
| Resistance Level | $17.18 | $1.37 |
| Average True Range (ATR) | 0.93 | 0.10 |
| MACD | -0.21 | -0.05 |
| Stochastic Oscillator | 4.88 | 0.29 |
Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.